| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Laboratory of Leukocyte Biology, Instituto de Biología y Genética Molecular, Facultad de Medicina, CSIC-Universidad de Valladolid, C/Ramón y Cajal 7, E-47005 Valladolid, Spain [F. M., C. G., B. M-M., R. M-D.]; Servicio de Inmunología, Hospital Universitario Marques de Valdecilla, INSALUD, E-39008 Santander, Spain [J. L. F-L., A. B.]; and Max-Planck-Institut für Immunbiologie, D-79108 Freiburg, Germany [M. M.]
The ether lipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (ET-18-OCH3; Edelfosine) has been shown to be a rapid inducer of apoptosis in human leukemic cells and has been considered as a promising drug in cancer treatment. Here we have found that Et-18-OCH3 induced apoptosis not only in human tumor cell lines but also in primary tumor cell cultures from cancer patients. Human leukemic cells were highly sensitive to ET-18-OCH3, whereas normal cells remained unaffected. Among the distinct modifications of the ET-18-OCH3 molecule assayed, we found that substitutions in positions sn-2 and sn-3 of the glycerol backbone resulted in a complete loss of its capacity to induce apoptosis, highlighting the importance of the molecular structure of ET-18-OCH3 in its apoptotic effect. Induction of apoptosis by ET-18-OCH3 was very well correlated with the uptake of this ether lipid. ET-18-OCH3-resistant 3T3 fibroblasts became sensitive and incorporated significant amounts of the ether lipid following transformation with the SV40 virus. ET-18-OCH3-induced apoptosis as well as ET-18-OCH3 uptake were not mediated through binding of the ether lipid to the platelet-activating factor receptor. Overexpression of bcl-2 or bcl-xL by gene transfer in the human erythroleukemic HEL cells abrogated apoptosis induced by ET-18-OCH3. ET-18-OCH3 did not affect the expression of bcl-2, bcl-xL, or bax in HEL and HL-60 human leukemic cells but induced expression of c-myc, an important effector of apoptosis in several systems. Thus, ET-18-OCH3 behaves as a potent and highly selective antitumor drug able to induce an apoptotic pathway of cell death in tumor cells but not in nonmalignant cells.
1 This work was supported in part by Grant FIS96/1434 from Fondo de Investigación Sanitaria, Grant VA71/96 from Junta de Castilla y León, Grant SAF96/0274 from Comision Interministerial de Ciencia y Tecnología, Grant PB95/0713 from Dirección General de Ciencia y Tecnología, and Grants 168A and AI-40/96 from Acciones Integradas Hispano-Alemanas. C. G. is a recipient of a fellowship from "Fondo de Investigación Sanitaria."
2 To whom requests for reprints should be addressed. Phone: 34-83-423062; Fax: 34-83-423588.
Received 10/ 9/96. Accepted 2/ 2/97.
This article has been cited by other articles:
![]() |
T. Nieto-Miguel, R. I. Fonteriz, L. Vay, C. Gajate, S. Lopez-Hernandez, and F. Mollinedo Endoplasmic Reticulum Stress in the Proapoptotic Action of Edelfosine in Solid Tumor Cells Cancer Res., November 1, 2007; 67(21): 10368 - 10378. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. van der Luit, S. R. Vink, J. B. Klarenbeek, D. Perrissoud, E. Solary, M. Verheij, and W. J. van Blitterswijk A new class of anticancer alkylphospholipids uses lipid rafts as membrane gateways to induce apoptosis in lymphoma cells Mol. Cancer Ther., August 1, 2007; 6(8): 2337 - 2345. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gajate and F. Mollinedo Edelfosine and perifosine induce selective apoptosis in multiple myeloma by recruitment of death receptors and downstream signaling molecules into lipid rafts Blood, January 15, 2007; 109(2): 711 - 719. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nyakern, A. Cappellini, I. Mantovani, and A. M. Martelli Synergistic induction of apoptosis in human leukemia T cells by the Akt inhibitor perifosine and etoposide through activation of intrinsic and Fas-mediated extrinsic cell death pathways. Mol. Cancer Ther., June 1, 2006; 5(6): 1559 - 1570. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nieto-Miguel, C. Gajate, and F. Mollinedo Differential Targets and Subcellular Localization of Antitumor Alkyl-lysophospholipid in Leukemic Versus Solid Tumor Cells J. Biol. Chem., May 26, 2006; 281(21): 14833 - 14840. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Zaremberg, C. Gajate, L. M. Cacharro, F. Mollinedo, and C. R. McMaster Cytotoxicity of an Anti-cancer Lysophospholipid through Selective Modification of Lipid Raft Composition J. Biol. Chem., November 11, 2005; 280(45): 38047 - 38058. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rahmani, E. Reese, Y. Dai, C. Bauer, S. G. Payne, P. Dent, S. Spiegel, and S. Grant Coadministration of Histone Deacetylase Inhibitors and Perifosine Synergistically Induces Apoptosis in Human Leukemia Cells through Akt and ERK1/2 Inactivation and the Generation of Ceramide and Reactive Oxygen Species Cancer Res., March 15, 2005; 65(6): 2422 - 2432. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gajate, E. del Canto-Janez, A. U. Acuna, F. Amat-Guerri, E. Geijo, A. M. Santos-Beneit, R. J. Veldman, and F. Mollinedo Intracellular Triggering of Fas Aggregation and Recruitment of Apoptotic Molecules into Fas-enriched Rafts in Selective Tumor Cell Apoptosis J. Exp. Med., August 2, 2004; 200(3): 353 - 365. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Perez-Victoria, F. Gamarro, M. Ouellette, and S. Castanys Functional Cloning of the Miltefosine Transporter: A NOVEL P-TYPE PHOSPHOLIPID TRANSLOCASE FROM LEISHMANIA INVOLVED IN DRUG RESISTANCE J. Biol. Chem., December 12, 2003; 278(50): 49965 - 49971. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. Hanson, L. Malone, J. L. Birchmore, and J. W. Nichols Lem3p Is Essential for the Uptake and Potency of Alkylphosphocholine Drugs, Edelfosine and Miltefosine J. Biol. Chem., September 19, 2003; 278(38): 36041 - 36050. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gajate, F. An, and F. Mollinedo Rapid and Selective Apoptosis in Human Leukemic Cells Induced by Aplidine through a Fas/CD95- and Mitochondrial-mediated Mechanism Clin. Cancer Res., April 1, 2003; 9(4): 1535 - 1545. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gajate, F. An, and F. Mollinedo Differential Cytostatic and Apoptotic Effects of Ecteinascidin-743 in Cancer Cells. TRANSCRIPTION-DEPENDENT CELL CYCLE ARREST AND TRANSCRIPTION-INDEPENDENT JNK AND MITOCHONDRIAL MEDIATED APOPTOSIS J. Biol. Chem., October 25, 2002; 277(44): 41580 - 41589. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. van der Luit, M. Budde, P. Ruurs, M. Verheij, and W. J. van Blitterswijk Alkyl-lysophospholipid Accumulates in Lipid Rafts and Induces Apoptosis via Raft-dependent Endocytosis and Inhibition of Phosphatidylcholine Synthesis J. Biol. Chem., October 11, 2002; 277(42): 39541 - 39547. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gajate and F. Mollinedo The antitumor ether lipid ET-18-OCH3 induces apoptosis through translocation and capping of Fas/CD95 into membrane rafts in human leukemic cells Blood, December 15, 2001; 98(13): 3860 - 3863. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sano, X. Zhu, H. Sano, N. M. Munoz, E. Boetticher, and A. R. Leff Regulation of eosinophil function by phosphatidylinositol-specific PLC and cytosolic PLA2 Am J Physiol Lung Cell Mol Physiol, October 1, 2001; 281(4): L844 - L851. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. VRABLIC, C. D. ALBRIGHT, C. N. CRACIUNESCU, R. I. SALGANIK, and S. H. ZEISEL Altered mitochondrial function and overgeneration of reactive oxygen species precede the induction of apoptosis by 1-O-octadecyl-2-methyl-rac-glycero-3-phosphocholine in p53-defective hepatocytes FASEB J, August 1, 2001; 15(10): 1739 - 1744. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gajate, I. Barasoain, J. M. Andreu, and F. Mollinedo Induction of Apoptosis in Leukemic Cells by the Reversible Microtubule-disrupting Agent 2-Methoxy-5-(2',3',4'-trimethoxyphenyl)-2,4,6-cycloheptatrien-1-one: Protection by Bcl-2 and Bcl-XL and Cell Cycle Arrest Cancer Res., May 1, 2000; 60(10): 2651 - 2659. [Abstract] [Full Text] |
||||
![]() |
D. Strassheim, S. H. Shafer, S. H. Phelps, and C. L. Williams Small Cell Lung Carcinoma Exhibits Greater Phospholipase C-{beta}1 Expression and Edelfosine Resistance Compared with Non-Small Cell Lung Carcinoma Cancer Res., May 1, 2000; 60(10): 2730 - 2736. [Abstract] [Full Text] |
||||
![]() |
O. Cuvillier, E. Mayhew, A. S. Janoff, and S. Spiegel Liposomal ET-18-OCH3 Induces Cytochrome c-Mediated Apoptosis Independently of CD95 (APO-1/Fas) Signaling Blood, November 15, 1999; 94(10): 3583 - 3592. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Ruiter, S. F. Zerp, H. Bartelink, W. J. van Blitterswijk, and M. Verheij Alkyl-Lysophospholipids Activate the SAPK/JNK Pathway and Enhance Radiation-induced Apoptosis Cancer Res., May 1, 1999; 59(10): 2457 - 2463. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gajate, A. Santos-Beneit, M. Modolell, and F. Mollinedo Involvement of c-Jun NH2-Terminal Kinase Activation and c-Jun in the Induction of Apoptosis by the Ether Phospholipid 1-O-Octadecyl-2-O-methyl-rac-glycero-3-phosphocholine Mol. Pharmacol., April 1, 1998; 53(4): 602 - 612. [Abstract] [Full Text] |
||||
![]() |
S. P. Whitman, F. Civoli, and L. W. Daniel Protein Kinase Cbeta II Activation by 1-beta -D-Arabinofuranosylcytosine Is Antagonistic to Stimulation of Apoptosis and Bcl-2alpha Down-regulation J. Biol. Chem., September 19, 1997; 272(38): 23481 - 23484. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |